Research Paper Volume 11, Issue 6 pp 1716—1732
Elevated FPR confers to radiochemoresistance and predicts clinical efficacy and outcome of metastatic colorectal cancer patients
Figure 5. Prognostic nomograms with or without FPR for predicting survival of mCRC patient. (a) nomogram including FPR for predicting 3 years’ PFS; (b) nomogram without FPR for predicting 3 years’ PFS; (c) nomogram including FPR for predicting 3 years’ OS; (d) nomogram without FPR for predicting 3 years’ OS.